跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE PLUS MENTHOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE PLUS MENTHOL
Authorized
STANDARD
LIDOCAINE PLUS MENTHOL
the mentholatum company of canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3cf564285327cf32
Company
the mentholatum company of canada ltd
Type
Standard
Approval Details
Approval Id
3cf564285327cf32
Drug Approval Canada Name
LIDOCAINE PLUS MENTHOL
Product Name
LIDOCAINE PLUS MENTHOL
Status
Cancelled Post Market
Status Date
2021-06-18
Original Market Date
2019-05-21
Din
02485338
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:08.00
Atc Original
D04AB01 LIDOCAINE
Atc Name
d 04 ab 01
Aig Number
0233049001
Company Name
the mentholatum company of canada ltd
Company Address
UNIT 205B, 110 Hannover Dr., St. Catharines, Ontario, Canada, L2W 1A4
Active Ingredients
MENTHOL
1 % / W/W
LIDOCAINE HYDROCHLORIDE
4 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3cf564285327cf32
Type
Standard
Back to Health Canada Approvals